UBS Upgrades Clorox to Neutral, Raises Price Target to $132
Portfolio Pulse from Benzinga Newsdesk
UBS analyst Peter Grom has upgraded Clorox (NYSE:CLX) from Sell to Neutral and raised the price target from $124 to $132.
November 06, 2023 | 10:20 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
UBS has upgraded Clorox from Sell to Neutral and raised the price target from $124 to $132, which could potentially lead to a positive market reaction.
The upgrade from Sell to Neutral by UBS indicates a change in the firm's outlook towards Clorox. The increase in price target from $124 to $132 suggests that UBS sees potential for the stock's price to rise. This could lead to a positive market reaction in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100